They hope the market will gain momentum from deal roadshows this week by Coditel and Capsugel, even though volatility is expected to persist, as more gloomy headlines about sovereign credit risk emerge.
"It would be a good sign for the market if Coditel gets done — that there ...Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
